企業プロフィール
Nuvectis Pharma 株価・ニュース・カタリスト
- ティッカー:
- NVCT
- 取引所:
- NYSE
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
23.56 USD (+0.90%)
終値
最終更新: 2026年8月21日
252M USD
時価総額
株価変動の要因
As of Aug 21, 2026, NVCT closed up 0.90% at $23.56. No new same-company headline was identified in the current news window.
企業概要
事業概要
Nuvectis Pharma is an oncology company focused on targeted therapies for difficult cancers. Its development story is centered on precision oncology and smaller, data-sensitive programs.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Nuvectis sits in specialty oncology biotechnology.
ビジネスモデルの特徴
The business depends on proof-of-concept, program prioritization, and the ability to build a differentiated oncology franchise.
バイオ業界での位置付け
Nuvectis is a small-cap oncology catalyst name whose valuation can move sharply on early data.
今後のカタリスト
- Nuvectis’s catalysts are NXP900 and NXP800, the two oncology assets that define the story. The market will care about whether either program can show real differentiation.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。